Sangamo Therapeutics Inc (NAS:SGMO)
$ 2.3 0.16 (7.48%) Market Cap: 479.89 Mil Enterprise Value: 468.41 Mil PE Ratio: 0 PB Ratio: 12.23 GF Score: 47/100

Q4 2018 Sangamo Therapeutics Inc Earnings Call Transcript

Feb 28, 2019 / 10:00PM GMT
Release Date Price: $9.01 (-3.33%)
Operator

Good afternoon, and welcome to the Sangamo Therapeutics Teleconference to discuss fourth quarter and full year 2018 financial results. This call is being recorded.

I will now pass you over to the coordinator of this event, McDavid Stilwell, Vice President of Corporate Communications and Investor Relations.

McDavid Stilwell
Sangamo Therapeutics, Inc. - VP of Corporate Communications & IR

Hello, and thank you for joining us. As we begin, I'd like to point out that we'll be referencing an accompanying slide presentation. A link to the slide presentation may be found on our website, sangamo.com, on the Events + Presentations page of the Investors + Media section of the site.

I'd also like to remind everyone that the projections and forward-looking statements that we'll discuss during this conference call are based upon information that we have available today. This information will likely change over time. By discussing the future performance of Sangamo with you today, we are not undertaking an obligation to provide updates in the future.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot